EDGAR Filing Documents for 0001144204-17-027803

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001144204-17-027803

Filing Date

2017-05-16

Accepted

2017-05-16 09:31:21

Documents

Period of Report

2017-05-16

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	v467168_4.html	4
1	OWNERSHIP DOCUMENT	v467168_4.xml	4	3105
	Complete submission text file	0001144204-17-027803.txt		4743

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100

Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488

Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, #455 CARMIEL L3 20100

Business Address

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 17847307